Incorporated in 1973, Alkem Labs is leading India based pharmaceutical company engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.
Alkem Labs produces branded generics, generic drugs, active pharmaceutical ingredients and neutraceuticals, which they market in India and 55 countries internationally, primarily the United States.
Company's pharmaceutical business is organized into domestic and international operations. Alkem Labs has a portfolio of over 736 brands in India. Company's most significant therapeutic areas in domestic market are anti-infectives, gastro-intestinal, pain and analgesics, and vitamins, minerals and nutrients.
Alkem Labs have a total of 16 manufacturing facilities: 14 manufacturing facilities at five locations in India and two in the United States. Company have four research and development facilities, two in India and two in the United States. As of June 30, 2015, company employed 483 scientists in research and development functions.
Highlights:
1. Alkem Labs is 5th largest pharmaceutical company in India in terms of domestic sales.
2. Alkem Labs products are also sold in 56 countries. In the United States, company has filed 66 abbreviated new drug applications.
3. Company sells a range of high-quality, cost effective generic drugs to major drug chains, pharmaceutical retailers, wholesalers, food and grocery stores, distributors and managed care companies in the United States.
Alkem Labs has 23 Promoters who jointly hold 64,302,440 Equity Shares of the Company which, in aggregate, constitutes 53.8% of the issued and paid-up Equity Share capital of our Company.
| Particulars | For the year/period ended (in Rs. Million) | |||
| 31 Mar 15 | 31 Mar 14 | 31 Mar 13 | 31 Mar 12 | |
| Total Income | 33,595.20 | 28,395.80 | 24,690.10 | 20,640.10 |
| Profit After Tax (PAT) | 4,370.90 | 4,402.00 | 4,667.80 | 4,318.10 |
The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
2. For the sale of 12,853,442 Equity Shares by the Selling Shareholders.
| IPO Date | Dec 8, 2015 - Dec 10, 2015 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 12,853,442 Eq Shares of ₹2 (aggregating up to ₹1,349.61 Cr) |
| Face Value | ₹2 Per Equity Share |
| IPO Price | ₹1020 to ₹1050 Per Equity Share |
| Market Lot | 14 Shares |
| Min Order Quantity | 14 Shares |
| Listing At | BSE, NSE |
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 14 | ₹14,700 |
| Maximum | 13 | 182 | ₹191,100 |
No. of Times Issue Subscribed (BSE + NSE) | |||||
|---|---|---|---|---|---|
As on Date & Time | QIB | NII | RII | Employee | Total |
Shares Offered | 2,510,906 | 1,883,179 | 4,394,086 | 298,913 | 9,087,084 |
Dec 10, 2015 23:15 | 57.19x | 129.96x | 3.17x | 0.67x | 44.29x |
| Listing Date | Wednesday, December 23, 2015 |
| BSE Script Code | 539523 |
| NSE Symbol | ALKEM |
| Listing In | B |
| ISIN | INE540L01014 |
| IPO Price | ₹1050 Per Equity Share |
| Face Value | ₹2 Per Equity Share |
|
|
|
Alkem Laboratories Limited
Alkem House,
Senapati Bapat Marg,
Lower Parel, Mumbai 400 013
Phone: +91 22 3982 9999
Email: investors@alkem.com
Website: http://www.alkemlabs.com/
Link Intime India Private Ltd
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Phone: +91-22-4918 6270
Email: all.ipo@linkintime.co.in
Website: http://www.linkintime.co.in
Alkem Laboratories IPO is a main-board IPO of 12,853,442 equity shares of the face value of ₹2 aggregating up to ₹1,349.61 Crores.
The issue price of the IPO is ₹1020 to ₹1050 Per Equity Share. The minimum order quantity is 14 Shares per application and the offer type is Book Built Issue.
The IPO opens on Dec 8, 2015 and closes on Dec 10, 2015.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Alkem Laboratories IPO opens on Dec 8, 2015 and closes on Dec 10, 2015.
Alkem Laboratories IPO application can be done through banks using ASBA online or through stock brokers trading account using UPI. All popular banks i.e. HDFC, ICICI, and SBI offer online IPO applications. An investor can also apply directly through their broker (i.e. Zerodha, Sharekhan) using UPI as a payment method.
The finalization of Basis of Allotment for Alkem Laboratories IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Alkem Laboratories IPO allotment status.
Alkem Laboratories IPO lot size is 14 Shares and the minimum order quantity is 14 Shares.
Guaranteed Save 60% to 90% Brokerage
You could reduce the brokerage cost significantly by moving to another stock broker. Our expert team compared top share brokers in India to help traders. STOP paying Demat AMC, Brokerage in %, PCM Fee and High Stamp Duty today.
We can help you choosing the right broker. Contact us today...
Useful Articles
Best of
Top Stock Brokers in India Top 10 Discount Brokers Top 10 Full-Service Brokers Lifetime Free Demat Account Best Broker for Beginners More Reports...Reviews (Discount Broker)
5paisa (₹20/trade) Zerodha (₹20/trade) ProStocks (₹899 Unlimited) Upstox RKSV (₹20) Edelweiss (₹10 per Trade) More Brokers...Compare Brokers
Broker Articles / Tutorials Compare Share Brokers Side-by-Side Comparison Broker Complaints Monitor Broker Glossary Special OffersTrading Platform Reviews
Zerodha Kite Review Sharekhan TradeTiger Omnesys NEST Review ODIN Review NSE NOW Review More Reviews...Message Board
Stock Message BoardOptions Basics
Options Overview Benefits & Risks of Options Options Pricing More Articles... Options Trading FAQs Options Trading GlossaryBroker Reviews
Zerodha Review 5paisa Review ProStocks Review Sharekhan Review Angel Broking Review ICICI DirectOptions Trading Platform
Kite Zerodha Trade Tiger Sharekhan Omnisys NEST Upstox RKSV Fyers One Fyers ScalperT FinvasiaHistory of Chittorgarh
History of Chittorgarh Maharana Pratap Meera Bai Panna Dhai Rani Padmini Jainism & Chittor (Hindi)Chittorgarh City Info
Chittorgarh City Map Hotels / Resorts Sainik School Chittorgarh Cement Industry Hindustan Zinc
IPO Guru (3900+ Posts, 4400+ Likes)